Phase II trial of menogaril in advanced
β
Eduard E. Holdener; Wim W. Bokkel Huinink; Genevieve Decoster; Christian Ludwig;
π
Article
π
1988
π
Springer US
π
English
β 262 KB
Menogaril, a new semisynthetic anthracycline antibiotic, was administered to 35 patients with advanced colorectal cancer. The drug was infused over 2 hr at a dose of 160 mg/sqm or 200 mg/sqm repeated every 4 weeks. Twenty-seven patients were evaluable for response and no objective responses were ach